Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Journal of Personalized Medicine|April 30, 2021
Thermal Liquid Biopsy (TLB) of Blood Plasma as a Potential Tool to Help in the Early Diagnosis of Multiple SclerosisFerdinanda Annesi, Sonia Hermoso-Durán, Bruno Rizzuti, et al.
European Biophysics Journal : EBJ|April 10, 2021
Uncertainty in protein-ligand binding constants: asymmetric confidence intervals versus standard errorsVaida Paketurytė, Vytautas Petrauskas, Asta Zubrienė, et al.
Biochimica Et Biophysica Acta. General Subjects|April 30, 2018
Thermal liquid biopsy for monitoring melanoma patients under surveillance during treatment: A pilot studyAdrian Velazquez-Campoy, Sonia Vega, Oscar Sanchez-Gracia, et al.
International Journal of Biological Macromolecules|July 3, 2023
The intrinsically disordered, epigenetic factor RYBP binds to the citrullinating enzyme PADI4 in cancer cellsSalomé Araujo-Abad, María Fuentes-Baile, Bruno Rizzuti, et al.
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M<sup>pro</sup> Main Protease InhibitorsMaria Nuria Peralta-Moreno, Vanessa Anton-Muñoz, David Ortega-Alarcon, et al.
Biomacromolecules|May 14, 2003
Epoxy-amino groups: a new tool for improved immobilization of proteins by the epoxy methodCesar Mateo, Rodrigo Torres, Gloria Fernández-Lorente, et al.
Scientific Reports|November 28, 2024
Development of an efficient NUPR1 inhibitor with anticancer activityXi Liu, Ana Jimenez-Alesanco, Zexian Li, et al.
Journal of Chemical Information and Modeling|November 22, 2021
Discovery of Diverse Natural Products as Inhibitors of SARS-CoV-2 M<sup>pro</sup> Protease through Virtual ScreeningJaime Rubio-Martínez, Ana Jiménez-Alesanco, Laura Ceballos-Laita, et al.
Scientific Reports|February 3, 2025
Identification of new ClpC1-NTD binders for Mycobacterium tuberculosis drug developmentKatharina Weinhäupl, Louis Meuret, Sandy Desrat, et al.
International Journal of Molecular Sciences|June 19, 2024
Shedding Light on Dark Chemical Matter: The Discovery of a SARS-CoV-2 M<sup>pro</sup> Main Protease Inhibitor through Intensive Virtual Screening and In Vitro EvaluationMaria Nuria Peralta-Moreno, Yago Mena, David Ortega-Alarcon, et al.
Pageof 9